Page 13 - Haematologica August 2018

haematologica Journal of the European Hematology Association
Published by the Ferrata Storti Foundation
e348 Molecular genetic characterization of myeloid/lymphoid neoplasms associated with eosinophilia and rearrangement of PDGFRA, PDGFRB, FGFR1 or PCM1-JAK2
Constance Baer et al. http://www.haematologica.org/content/103/8/e348
e351 Automated decision tree to evaluate genetic abnormalities when determining prognostic risk in acute myeloid leukemia Kevin Watanabe-Smith et al.
http://www.haematologica.org/content/103/8/e351
e356 Increased rituximab exposure does not improve response and outcome of patients with chronic lymphocytic leukemia after fludarabine, cyclophosphamide, rituximab. A French Innovative Leukemia Organization (FILO) study
Guillaume Cartron et al.
http://www.haematologica.org/content/103/8/e356
e360 RNA fusions involving CD28 are rare in peripheral T-cell lymphomas and concentrate mainly in those derived from follicular helper T cells David Vallois et al.
http://www.haematologica.org/content/103/8/e360
e364 Impact of age on genetics and treatment efficacy in follicular lymphoma Stefan Alig et al.
http://www.haematologica.org/content/103/8/e364
e368 Cereblon loss and up-regulation of c-Myc are associated with lenalidomide resistance in multiple myeloma patients Laurens E. Franssen et al.
http://www.haematologica.org/content/103/8/e368
Case Reports
Case Reports are available online only at www.haematologica.org/content/103/8.toc
e372 Germline JAK2 L611S mutation in a child with thrombocytosis Bernard Aral et al.
http://www.haematologica.org/content/103/8/e372
e374 True, true unrelated? Coexistence of Waldenström macroglobulinemia and cardiac transthyretin amyloidosis Avinainder Singh et al.
http://www.haematologica.org/content/103/8/e374
e377 BRAF V600E mutation detected in a case of Rosai-Dorfman disease Giancarlo Fatobene et al.
http://www.haematologica.org/content/103/8/e377
Comments
Comments are available online only at www.haematologica.org/content/103/8.toc
e380 Unproven value of end-of-treatment and serial follow-up FDG-PET in primary mediastinal B-cell lymphoma Hugo J.A. Adams et al.
http://www.haematologica.org/content/103/8/e380
e382 End-of-treatment and serial PET imaging has prognostic value and clinical utility in primary mediastinal B-cell lymphoma following dose-adjusted EPOCH-R - Response to Adams et al.
Christopher Melani et al.
http://www.haematologica.org/content/103/8/e382
Haematologica 2018; vol. 103 no. 8 - August 2018 http://www.haematologica.org/